Nykode Therapeutics’ Chair, Board Members, CEO, CSO and CFO to resign

The industry members now include both a Dane, a Swede, a Norwegian and a Finn.

After 36 years, my chapter at Novo Nordisk is coming to a close, writes the inventor of the GLP-1 receptor agonist liraglutide on LinkedIn.

Pernilla Sandwall and Marie Gårdmark bring extensive senior leadership experience from the life sciences sector with special focus on clinical research and regulatory strategy in pharma/medtech development.

Grape is to be appointed Special Advisor on antimicrobial resistance (AMR) to the WHO European Region.

The appointment of Agneta Wennerholm supports the company's preparations for the clinical development of TIR-C, a novel immunomodulatory drug candidate for the treatment of atopic dermatitis (eczema).

Guillaume Joucla has been appointed interim CEO of Mölnlycke, following Zlatko Rihter's decision to resign after more than five years as CEO.

Markus Kede will join the Executive Leadership Team and report to President and CEO, Charl van Zyl.